Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ANTI-CD38 ANTIBODY AND LENALIDOMIDE OR BORTEZOMIB FOR THE TREATMENT OF MULTIPLE MYELOMA AND NHL

No-Receipt date 2017-00710 - 24/02/2017
No-Filing date 20170400619 - 24/02/2017
No-Granting date 3091671 - 27/04/2017
No-EPO application date 11761360.4 - 26/09/2011
No-EPO granting date 2621531 - 30/11/2016
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 4/2017 - 03/07/2017
Expiration date 27/09/2031
Kind of title Validation of European Patent
Legal status VALID
Priorities US201161486814 P17/05/2011/US
US201161468607 P29/03/2011/US
US201161437696 P31/01/2011/US
US386619 P27/09/2010/US
EP1018048527/09/2010/EP
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/454
A61K 31/69
A61K 38/05
A61K 38/07
A61K 39/395
A61K 45/06
A61P 35/00
C07K 16/28
C07K 16/30

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
742539 MORPHOSYS AG LENA-CHRIST-STRASSE 4882152 MARTINSRIED/MUNCHEN GERMANY

Inventors
CodeFirstnameSurname
1823230 ROJKJAER, LISA
1823231 BOXHAMMER, RAINER
1823232 ENDELL, JAN
1823233 WINDERLICH, MARK
1823234 SAMUELSSON, CHRISTOFER

Representatives
CodeFirstnameSurnameAddressTownZip
1602AIKATERINISIOTOUPATISION 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 14 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015